What is ResMed's sleep and respiratory care — d&a?

ResMed (RMD) reported sleep and respiratory care — d&a of $21.76M in Q2 2024.

How has ResMed's sleep and respiratory care — d&a changed year-over-year?

ResMed's sleep and respiratory care — d&a decreased by 5.6% year-over-year, from $23.04M to $21.76M.

What is the long-term trend for ResMed's sleep and respiratory care — d&a?

Over 2 years (2022 to 2024), ResMed's sleep and respiratory care — d&a has grown at a 4.1% compound annual growth rate (CAGR), from $79.37M to $86.07M.

What does sleep and respiratory care — d&a mean?

The annual non-cash expense representing the wear and aging of assets used in the respiratory business.

Discontinued — last reported Q2 '24

Business Segments · D&A

Sleep and Respiratory Care — D&A

ResMed Sleep and Respiratory Care — D&A decreased by 0.3% to $21.76M in Q2 2024 compared to the prior quarter. Year-over-year, this metric declined by 5.6%, from $23.04M to $21.76M. Over 2 years (FY 2022 to FY 2024), Sleep and Respiratory Care — D&A shows relatively stable performance with a 4.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment

CategoryEfficiency

SignalLower is better

VolatilityStable

First reportedQ3 2020

Last reportedQ2 2024

Rolls up toD&A

How to read this metric

Increasing levels may suggest higher capital intensity or recent investments in manufacturing infrastructure.

Detailed definition

The systematic allocation of the cost of tangible fixed assets and intangible assets over their useful lives within the...

Peer comparison

Standard operating expense for capital-intensive manufacturing firms; peers typically report this in the cash flow statement or segment notes.

Metric ID: rmd_segment_sleep_and_respiratory_care_depreciation_and_amortization

Historical Data

12 periods

	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24
Value	$18.02M	$19.35M	$21.01M	$21.00M	$19.77M	$18.53M	$21.20M	$23.04M	$20.52M	$21.96M	$21.83M	$21.76M
QoQ Change	—	+7.4%	+8.6%	-0.1%	-5.8%	-6.2%	+14.4%	+8.7%	-11.0%	+7.0%	-0.6%	-0.3%
YoY Change	—	—	—	—	+9.7%	-4.2%	+0.9%	+9.8%	+3.8%	+18.5%	+3.0%	-5.6%

Range$18.02M – $23.04M

CAGR+7.1%

Avg YoY Growth+4.5%

Median YoY Growth+3.4%

Current Streak2 quarters decline

Similar Metrics at Other Companies

Ingersoll RandIR View metric

QSR

Restaurant Brands InternationalQSR View metric

Republic ServicesRSG View metric

Ingersoll RandIR View metric

GE HealthCare TechnologiesGEHC View metric

Frequently Asked Questions

What is ResMed's sleep and respiratory care — d&a?: ResMed (RMD) reported sleep and respiratory care — d&a of $21.76M in Q2 2024.
How has ResMed's sleep and respiratory care — d&a changed year-over-year?: ResMed's sleep and respiratory care — d&a decreased by 5.6% year-over-year, from $23.04M to $21.76M.
What is the long-term trend for ResMed's sleep and respiratory care — d&a?: Over 2 years (2022 to 2024), ResMed's sleep and respiratory care — d&a has grown at a 4.1% compound annual growth rate (CAGR), from $79.37M to $86.07M.
What does sleep and respiratory care — d&a mean?: The annual non-cash expense representing the wear and aging of assets used in the respiratory business.